Viemed Healthcare, Inc. (VMD): who owns it and who trades it
As of Nov 16, 2026, VMD insiders reported 9 open-market sales worth $1.6M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Michael Moore (President), with $1.2M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Viemed Healthcare
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds mostly bought. Famous investors was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns VMD
167 funds and institutions reported VMD shares worth $311M at the end of Q2 2026, about 71% of the company. The largest holder is BlackRock, Inc. with 12.5%.
Funds and institutions (13F) 71%Everyone else 29%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 4.79M | 12.49% | $54.6M | +4% |
| Forager Capital Management, LLC | 2.14M | 5.59% | $24.4M | -24% |
| Vanguard Capital Management LLC | 1.32M | 3.45% | $15.1M | +1% |
| Nantahala Capital Management, LLC | 1.26M | 3.30% | $14.4M | +43% |
| Goldman Sachs Group Inc | 1.22M | 3.19% | $13.9M | -14% |
| First Eagle Investment Management, LLC | 1.07M | 2.79% | $12.2M | +102% |
| Ameriprise Financial Inc | 1.01M | 2.62% | $11.5M | +12% |
| Geode Capital Management, LLC | 973,744 | 2.54% | $11.1M | +25% |
| Raffles Associates LP | 807,382 | 2.11% | $9.2M | +95% |
| Arrowstreet Capital, Limited Partnership | 786,269 | 2.05% | $9M | +11% |
| State Street Corp | 762,097 | 1.99% | $8.7M | +3% |
| Panagora Asset Management Inc | 538,625 | 1.40% | $6.1M | +14% |
| Punch & Associates Investment Management, Inc. | 533,466 | 1.39% | $6.1M | -1% |
| Two Sigma Investments, LP | 438,851 | 1.14% | $5M | +6% |
| Renaissance Technologies LLC | 425,900 | 1.11% | $4.9M | -4% |
| Acadian Asset Management LLC | 398,586 | 1.04% | $4.5M | +141% |
| Creative Planning | 360,356 | 0.94% | $4.1M | +63% |
| Tocqueville Asset Management L.P. | 342,100 | 0.89% | $3.9M | -28% |
| Martin & Co Inc | 340,771 | 0.89% | $3.9M | +25% |
| Bard Associates Inc | 339,672 | 0.89% | $3.9M | -0% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, VMD insiders reported $0 of open-market purchases and $1.6M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | William Frazier | Director | Sale | 10,000 | $11.72 | $117K | Form 4 |
| Jun 24, 2026 | Timothy Smokoff | Director | Sale | 3,364 | $11.50 | $38.7K | Form 4 |
| Jun 24, 2026 | Timothy Smokoff | Director | Sale | 5,000 | $11.56 | $57.8K | Form 4 |
| Jun 24, 2026 | Timothy Smokoff | Director | Sale | 5,000 | $11.41 | $57K | Form 4 |
| Jun 24, 2026 | Timothy Smokoff | Director | Sale | 1,636 | $11.48 | $18.8K | Form 4 |
| Jun 24, 2026 | Timothy Smokoff | Director | Sale | 5,000 | $11.53 | $57.6K | Form 4 |
| Mar 20, 2026 | Michael Moore | President | Sale | 65,000 | $8.77 | $570K | Form 4 |
| Mar 19, 2026 | Michael Moore | President | Sale | 40,232 | $9.21 | $371K | Form 4 |
| Mar 18, 2026 | Michael Moore | President | Sale | 31,570 | $9.42 | $297K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Michael Moore | President | – | $1.2M | Mar 20, 2026 |
| Timothy Smokoff | Director | – | $230K | Jun 24, 2026 |
| William Frazier | Chief Medical Officer, Director | – | $117K | Jun 25, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
VMD short interest
Low short interest. 4.0% of VMD shares are sold short: about 1 share in 25. Over the last 12 reports the number of shares short went up 269%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.51M VMD shares were sold short, 4.0% of the shares outstanding, down 1.7% from the report before. At the average daily volume of 177,313 shares, buying them all back would take about 8.5 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.51M | 3.98% | -2% | 177,313 | 8.5 |
| Oct 15, 2026 | 1.54M | 4.03% | -2% | 239,837 | 6.4 |
| Sep 30, 2026 | 1.57M | 4.12% | +19% | 276,955 | 5.7 |
| Sep 15, 2026 | 1.32M | 3.48% | +10% | 252,727 | 5.2 |
| Aug 31, 2026 | 1.21M | 3.17% | +53% | 430,040 | 2.8 |
| Aug 14, 2026 | 787,145 | 2.07% | +17% | 589,322 | 1.3 |
| Jul 31, 2026 | 671,738 | 1.76% | -10% | 270,103 | 2.5 |
| Jul 15, 2026 | 747,076 | 1.95% | +44% | 313,832 | 2.4 |
| Jun 30, 2026 | 519,096 | 1.35% | +12% | 441,622 | 1.2 |
| Jun 15, 2026 | 464,553 | 1.21% | -8% | 193,872 | 2.4 |
| May 29, 2026 | 502,837 | 1.31% | +23% | 215,545 | 2.3 |
| May 15, 2026 | 408,565 | 1.07% | -9% | 312,488 | 1.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Viemed Healthcare company events
Viemed Healthcare filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026ResultsReleased financial results. Filing
- Aug 20, 2026AnnouncementShared information with investors. Filing
- Aug 3, 2026ResultsReleased financial results. Filing
- Jun 4, 2026LeadershipViemed Healthcare, Inc. held its Annual General and Special Meeting of Shareholders on June 4, 2026. Filing
- Jun 2, 2026AnnouncementShared information with investors. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Mar 16, 2026AnnouncementShared information with investors. Filing
- Mar 4, 2026AnnouncementThe Company's Board of Directors authorized and approved a share repurchase program on Nasdaq. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Viemed Healthcare financials
Famous investors that hold VMD
4 of the 50 well-known investors we track reported holding VMD in their latest 13F filing. The largest position is Jim Simons's, worth $4.2M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 465,957 | $4.2M | 0.0% | +9% |
| Israel Englander · Millennium Management | Q3 2026 | 272,119 | $2.5M | 0.0% | +424% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 158,397 | $1.4M | 0.0% | -32% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 134,517 | $1.2M | 0.0% | -14% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Viemed Healthcare, Inc. (VMD) stock
Who owns the most VMD stock?
The largest reported owner of Viemed Healthcare, Inc. (VMD) is BlackRock, Inc., with 12.5% of the company. In total, 167 funds and institutions reported holding VMD at the end of Q2 2026, together about 71% of the shares. See the largest owners.
Are VMD insiders buying or selling?
In the last 12 months, VMD insiders reported no open-market purchases and 9 sales worth $1.6M. The latest trade was on Jun 25, 2026. See every trade.
What is the short interest in VMD?
As of Oct 30, 2026, 1.51M VMD shares were sold short, 4.0% of the shares outstanding, down 1.7% from the report before. At the average daily volume of 177,313 shares, buying them all back would take about 8.5 trading days (days to cover). See the history.
Which famous investors hold VMD?
4 of the 50 well-known investors we track reported VMD in their latest 13F filing, including Jim Simons, Israel Englander, Ken Griffin. The largest position is worth $4.2M. See all holders.
Executive pay
Viemed Healthcare's chief executive was paid a total of $2.6M for the year ended Dec 31, 2025, up 0% from $2.6M the year before. In the last 12 months, Viemed Healthcare's executives and directors bought no stock on the open market and sold $1.6M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.